-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
-
Summary
-
InMed Pharmaceuticals Inc. quarterly Accrued Liabilities, Current history and growth rate from Q2 2023 to Q2 2024.
- InMed Pharmaceuticals Inc. Accrued Liabilities, Current for the quarter ending June 30, 2024 was $256K, a 28.3% decline year-over-year.
Accrued Liabilities, Current, Quarterly (USD)
Accrued Liabilities, Current, YoY Quarterly Growth (%)